After 19 years in a minimally conscious state, a man recovered language and motor function. Diffusion tensor imaging showed reorganization of the patient's white matter, possibly facilitating functional recovery.
After 19 years in a minimally conscious state, a man recovered language and motor function. Diffusion tensor imaging showed reorganization of the patient's white matter, possibly facilitating functional recovery.
At the initial DTI evaluation by Henning U. Voss, Ph.D., a biomedical researcher at Cornell University, and colleagues, the patient already had regained limited movement, speech, and communication. DTI showed increased anisotropy (less water diffusion in white matter tracts, indicating recovery) in the medial parieto-occipital (MPO) areas compared with controls (J Clin Invest 2006;116:2005-2011).
Eighteen months later, at the time of a second scan, the patient's motor and cognitive functions had further improved. Interestingly, anisotropy in the MPO had decreased. Researchers theorize that the initial increase in anisotropy was a transitional stage of an ongoing axonal sprouting process. Once the new fiber tracts were laid down, anisotropy decreased as axons sprouted toward other targets.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.